About: Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $16.43 (-0.76%)
AUPH NASDAQ Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc share price
AUPH price activity
Last Price
$16.430
Change (24hr)
-0.13 USD (-0.76%)
Volume
534.14K
Volume (4w avg)
-
Open
$16.46
Day Range
$16.43 - $16.46
Previous Close
$16.55
Last Trade
13 Oct, 7:07 pm GMT+0
Delayed
13 Oct, 7:07 pm GMT+0
AUPH price performance
Delayed
13 Oct, 7:07 pm GMT+0
AUPH Market Signals